David Meline, incoming Moderna CFO

Am­gen vet David Meline finds a new CFO roost at Mod­er­na, tak­ing a ride on the Covid-19 tiger as de­part­ing ex­ec cash­es out with $12M

We found out a few weeks ago that Mod­er­na CFO Lorence Kim isn’t wait­ing around to see how the biotech wun­derkind makes out in its fran­tic race to field a mes­sen­ger RNA vac­cine that can quell Covid-19. And now we know who’s step­ping on board to take his place in the lat­est move in the ex­ec­u­tive suite.

David Meline, who forged his rep dur­ing a 6-year run at Am­gen, slipped out the ex­it right af­ter his Q2 “re­tire­ment” par­ty in Cal­i­for­nia — pre­sum­ably vir­tu­al — and start­ed the next chap­ter of his ca­reer at a biotech com­pa­ny bet­ting big on rev­o­lu­tion­iz­ing the vac­cine R&D space.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.